Arikketh Devi

2.3k total citations · 1 hit paper
78 papers, 1.3k citations indexed

About

Arikketh Devi is a scholar working on Molecular Biology, Cancer Research and Management Science and Operations Research. According to data from OpenAlex, Arikketh Devi has authored 78 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 27 papers in Cancer Research and 7 papers in Management Science and Operations Research. Recurrent topics in Arikketh Devi's work include Extracellular vesicles in disease (22 papers), MicroRNA in disease regulation (21 papers) and Cancer-related molecular mechanisms research (9 papers). Arikketh Devi is often cited by papers focused on Extracellular vesicles in disease (22 papers), MicroRNA in disease regulation (21 papers) and Cancer-related molecular mechanisms research (9 papers). Arikketh Devi collaborates with scholars based in India, United States and Australia. Arikketh Devi's co-authors include Rajib Dhar, Joel P. Joseph, M. Harishankar, Sukhamoy Gorai, Rama Jayaraj, Jean E. Vance, Randy Nelson, Αθανάσιος Αλεξίου, Marios Papadakis and Chellan Kumarasamy and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Arikketh Devi

70 papers receiving 1.3k citations

Hit Papers

Exosome-Based Smart Drug Delivery Tool for Cancer Therano... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arikketh Devi India 20 836 514 154 132 115 78 1.3k
Jungwoon Lee South Korea 20 799 1.0× 233 0.5× 163 1.1× 109 0.8× 81 0.7× 49 1.3k
Jiankang Zhou China 21 1.0k 1.3× 752 1.5× 203 1.3× 141 1.1× 111 1.0× 49 1.6k
Kailiang Zhang China 22 1.3k 1.5× 972 1.9× 171 1.1× 77 0.6× 77 0.7× 53 1.7k
Yongyi Huang China 26 1.0k 1.2× 754 1.5× 146 0.9× 182 1.4× 41 0.4× 63 1.8k
Weijun Su China 16 815 1.0× 305 0.6× 263 1.7× 134 1.0× 174 1.5× 36 1.3k
Sadegh Babashah Iran 23 1.4k 1.7× 1.1k 2.1× 208 1.4× 135 1.0× 81 0.7× 70 1.8k
Zheng Lian China 20 1.1k 1.3× 438 0.9× 156 1.0× 310 2.3× 128 1.1× 46 1.6k
Na Ding China 21 985 1.2× 471 0.9× 200 1.3× 122 0.9× 52 0.5× 78 1.6k
Xincheng Liu China 21 669 0.8× 392 0.8× 159 1.0× 88 0.7× 56 0.5× 68 1.2k
Guanghui Li China 22 621 0.7× 333 0.6× 264 1.7× 114 0.9× 115 1.0× 88 1.4k

Countries citing papers authored by Arikketh Devi

Since Specialization
Citations

This map shows the geographic impact of Arikketh Devi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arikketh Devi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arikketh Devi more than expected).

Fields of papers citing papers by Arikketh Devi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arikketh Devi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arikketh Devi. The network helps show where Arikketh Devi may publish in the future.

Co-authorship network of co-authors of Arikketh Devi

This figure shows the co-authorship network connecting the top 25 collaborators of Arikketh Devi. A scholar is included among the top collaborators of Arikketh Devi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arikketh Devi. Arikketh Devi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devi, Arikketh, et al.. (2025). Emerging Preclinical and Clinical Evidence on the Impact of Phytochemicals in Oral Cancer Metastasis. Oral Diseases. 31(6). 1564–1582. 1 indexed citations
2.
Dhar, Rajib, et al.. (2025). Clinical Impact of Exosome Chemistry in Cancer. ACS Applied Bio Materials. 8(3). 1862–1876. 2 indexed citations
4.
Devi, Arikketh, et al.. (2024). Landscape of scaffolds from advanced synthesis to tissue engineering. Materials Today Chemistry. 40. 102258–102258. 4 indexed citations
5.
Devi, Arikketh, et al.. (2024). The Impact of Internet Marketing in E-Commerce: A Case Study. International Journal of Case Studies in Business IT and Education. 326–339. 20 indexed citations
7.
Zelepukin, Ivan V., Gleb V. Tikhonowski, Anton A. Popov, et al.. (2024). Laser-synthesized plasmonic HfN-based nanoparticles as a novel multifunctional agent for photothermal therapy. Nanoscale. 16(38). 17893–17907. 2 indexed citations
8.
Sengupta, Raj, et al.. (2024). Exosomes and tumor virus interlink: A complex side of cancer. Pathology - Research and Practice. 266. 155747–155747. 1 indexed citations
9.
Dhar, Rajib, et al.. (2023). Theranostic signature of tumor-derived exosomes in cancer. Medical Oncology. 40(11). 321–321. 30 indexed citations
10.
Dhar, Rajib, Sukhamoy Gorai, Arikketh Devi, et al.. (2023). Exosome: A megastar of future cancer personalized and precision medicine. SHILAP Revista de lepidopterología. 3(3). 26 indexed citations
11.
Dhar, Rajib, Sukhamoy Gorai, Sagnik Nag, et al.. (2023). Exosomal miRNAs and breast cancer: a complex theranostics interlink with clinical significance. Biomarkers. 28(6). 502–518. 18 indexed citations
12.
Dhar, Rajib, Sukhamoy Gorai, Arikketh Devi, et al.. (2023). Decoding of exosome heterogeneity for cancer theranostics. Clinical and Translational Medicine. 13(6). e1288–e1288. 29 indexed citations
13.
Dhar, Rajib, Sukhamoy Gorai, Arikketh Devi, et al.. (2023). Exosome DNA: An untold story of cancer. SHILAP Revista de lepidopterología. 3(4). 22 indexed citations
14.
Dhar, Rajib, Sagnik Nag, Sukhamoy Gorai, et al.. (2023). Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics. ACS Biomaterials Science & Engineering. 9(2). 577–594. 147 indexed citations breakdown →
15.
Jayaraj, Rama, et al.. (2021). Notch Signalling: A Potential Therapeutic Pathway in Oral SquamousCell Carcinoma. Endocrine Metabolic & Immune Disorders - Drug Targets. 21(12). 2159–2168. 5 indexed citations
16.
Joseph, Joel P., et al.. (2018). Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC. Oral Oncology. 80. 23–32. 230 indexed citations
17.
ArulJothi, K.N., et al.. (2017). Genetic spectrum of low density lipoprotein receptor gene variations in South Indian population. Clinica Chimica Acta. 478. 28–36. 3 indexed citations
18.
Harishankar, M., et al.. (2017). Downregulation of Notch4 – a prognostic marker in distinguishing oral verrucous carcinoma from oral squamous cell carcinoma. Brazilian Journal of Otorhinolaryngology. 85(1). 11–16. 7 indexed citations
19.
Harishankar, M., et al.. (2015). Genotoxicity evaluation of metformin and glimepiride by micronucleus assay in exfoliated urothelial cells of type 2 diabetes mellitus patients. Food and Chemical Toxicology. 83. 146–150. 19 indexed citations
20.
Devi, Arikketh, et al.. (2010). Surface proteins and osteoblast markers: characterization of human adipose tissue-derived osteogenic cells. European Journal of Trauma and Emergency Surgery. 36(5). 457–463. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026